Inhibition mechanism of baicalein and Baicalin (cas 100647-26-5) on xanthine oxidase and their synergistic effect with allopurinol

Add time:08/12/2019    Source:sciencedirect.com

Suppression of xanthine oxidase (XO) may contribute to control hyperuricemia and gout. In this study, baicalein and Baicalin (cas 100647-26-5), two dietary flavones, were found to inhibit the formation of uric acid and generation of superoxide anion (O2−) catalysed by XO through interaction with primary amino acid residues located in flavin adenine dinucleotides center of XO. Baicalein or baicalin binding to XO mainly facilitated by hydrophobic interactions and hydrogen bonds resulted in more compact of XO structure. The concentration profiles and pure spectra of the components extracted from highly overlapping spectral signal by multivariate curve resolution–alternating least squares chemometrics algorithm confirmed the formation of complexes and monitored the reaction kinetics process between XO and these flavones. Furthermore, the isobolographic analysis found that baicalein or baicalin exhibited a moderate synergy on the inhibition of XO when it combined with allopurinol as well as the joint use of baicalein and baicalin.

We also recommend Trading Suppliers and Manufacturers of Baicalin (cas 100647-26-5). Pls Click Website Link as below: cas 100647-26-5 suppliers

Prev:Baicalin (cas 100647-26-5) regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production
Next:Large-scale separation of Baicalin (cas 100647-26-5) and wogonoside from Scutellaria baicalensis Georgi by the combination of pH-zone-refining and conventional counter-current chromatography)